152 related articles for article (PubMed ID: 2189213)
1. Laboratory measurement of lipid and lipoprotein risk factors.
Warnick GR
Scand J Clin Lab Invest Suppl; 1990; 198():9-19. PubMed ID: 2189213
[TBL] [Abstract][Full Text] [Related]
2. [Standardization of the methods of lipid determination according to WHO in the regional project of prevention of cardiovascular diseases in Friuli-Venezia Giulia].
Grafnetter D; Feruglio GA; Vanuzzo D
G Ital Cardiol; 1996 Mar; 26(3):287-97. PubMed ID: 8690184
[TBL] [Abstract][Full Text] [Related]
3. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements.
Myers GL; Cooper GR; Winn CL; Smith SJ
Clin Lab Med; 1989 Mar; 9(1):105-35. PubMed ID: 2538292
[TBL] [Abstract][Full Text] [Related]
4. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of two compact analyzers used for lipid analysis.
McKenney JM; Fary DF; Miller G; Proctor JD; Chinchili VM
J Fam Pract; 1993 May; 36(5):526-33. PubMed ID: 8482937
[TBL] [Abstract][Full Text] [Related]
6. [Reference values of serum lipid].
Seishima M; Niwa T; Maeda S
Rinsho Byori; 2001 Nov; 49(11):1115-21. PubMed ID: 11769557
[TBL] [Abstract][Full Text] [Related]
7. Reference system for cholesterol measurements.
Cooper GR; Myers GL
Scand J Clin Lab Invest Suppl; 1990; 198():27-31. PubMed ID: 2189207
[TBL] [Abstract][Full Text] [Related]
8. Role of lipid and lipoprotein profiles in risk assessment and therapy.
Ballantyne CM; Hoogeveen RC
Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
[TBL] [Abstract][Full Text] [Related]
9. Standardization of lipoprotein reporting.
Kroll MH; Cole TG; Rifai N; Cooper G; Warnick GR; Jialal I
Am J Clin Pathol; 2000 Nov; 114(5):696-702. PubMed ID: 11068542
[TBL] [Abstract][Full Text] [Related]
10. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
11. Quality specifications and the assessment of the biochemical risk of atherosclerosis.
Rifai N; Warnick GR
Clin Chim Acta; 2004 Aug; 346(1):55-64. PubMed ID: 15234636
[TBL] [Abstract][Full Text] [Related]
12. Matrix effects on proficiency testing materials. Impact on accuracy of cholesterol measurement in laboratories in the nation's largest hospital system.
Naito HK; Kwak YS; Hartfiel JL; Park JK; Travers EM; Myers GL; Ross JW; Eckfeldt JH; Hartmann AE
Arch Pathol Lab Med; 1993 Apr; 117(4):345-51. PubMed ID: 8466396
[TBL] [Abstract][Full Text] [Related]
13. Lipid and lipoprotein testing in resource-limited laboratories.
Myers GL
Ethn Dis; 2003; 13(2 Suppl 2):S107-9. PubMed ID: 13677424
[TBL] [Abstract][Full Text] [Related]
14. Lipid and lipoprotein measurements in a normal, adult Cuban population.
Paz Paula CM; Szollár LG; Tornóci L; Rischák K; Portilla del Canal A; Paz Paula ER; Camacho Machin ML
Acta Med Hung; 1989; 46(2-3):143-55. PubMed ID: 2812958
[TBL] [Abstract][Full Text] [Related]
15. Progeny's lipid and lipoprotein levels by parental mortality. The Lipid Research Clinics Program Prevalence Study.
Glueck CJ; Laskarzewski PM; Suchindran CM; Chambless LE; Barrett-Connor E; Stewart P; Heiss G; Tyroler HA
Circulation; 1986 Jan; 73(1 Pt 2):I51-61. PubMed ID: 3940684
[TBL] [Abstract][Full Text] [Related]
16. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Impact on the assessment of risk according to the National Cholesterol Education Program guidelines.
Bookstein L; Gidding SS; Donovan M; Smith FA
Arch Intern Med; 1990 Aug; 150(8):1653-7. PubMed ID: 2383160
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic determination of cholesterol and triglycerides in serum lipoprotein profiles by asymmetrical flow field-flow fractionation with on-line, dual detection.
Rambaldi DC; Reschiglian P; Zattoni A; Johann C
Anal Chim Acta; 2009 Nov; 654(1):64-70. PubMed ID: 19850170
[TBL] [Abstract][Full Text] [Related]
18. Lipoproteins and cardiovascular risk--from genetics to CHD prevention.
Cullen P; Funke H; Schulte H; Assmann G
Eur Heart J; 1998 Apr; 19 Suppl C():C5-11. PubMed ID: 9597420
[TBL] [Abstract][Full Text] [Related]
19. Lipid measurements for coronary risk assessment: a review.
Berg LH
Am J Med Technol; 1981 Jul; 47(7):539-43. PubMed ID: 7025628
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride measurement and its relationship to heart disease.
Stein EA; Steiner PM
Clin Lab Med; 1989 Mar; 9(1):169-85. PubMed ID: 2647372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
